Bezafibrate in skeletal muscle fatty acid oxidation disorders

Abstract

This study provides Class I evidence that bezafibrate 200 mg 3 times daily is ineffective in improving changes in FAO and HR during exercise in adults with CPT II and VLCAD deficiencies.